Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery

Kidney Function Tests Clinical Trial

Official title:
Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery

Status Completed

Clinical Trial Summary

Recent studies have shown an increased incidence of renal replacement therapy after the use of Hydroxyethylstarchs (HES) in patients admitted in the intensive care unit. However, studies showing detrimental effects of HES have been conducted in mostly non-surgical subjects. There are very few studies analyzing the effects of HES on renal function after cardiac surgery, a population already at risk of renal dysfunction.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Kidney Function Tests

Clinical Trial Details

NCT number	NCT02306213
Study type	Interventional
Source	Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Contact
Status	Completed
Phase	N/A
Start date	January 2011
Completion date	April 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06274125` - Evaluation of Kidney Damage Using NGAL Measurements
Terminated	`NCT03152084` - The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.	Phase 4
Completed	`NCT02695251` - AGE - Functional Reserve	N/A
Active, not recruiting	`NCT05232188` - Effect of Renal Access Sheath on Functions	N/A